Key Patent Covers Fundamental Methods for Producing RPE Cells from Embryonic Stem Cells Including IP Used in Phase I Trial to Treat Patients with Stargardt's Macular Dystrophy.
By : |
06-19-2010
|
Health and Fitness:Health and Fitness
| Total Views :
743